Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1995
08/23/1995EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof
08/23/1995EP0668352A1 Protein having TPO activity
08/23/1995EP0668351A1 Erythropoietin isoforms
08/23/1995EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
08/23/1995EP0667960A1 Suppport material for simultaneous binding of genotypic and phenotypic substances.
08/23/1995EP0667959A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE $g(b)-AMYLOID PEPTIDE
08/23/1995EP0667920A1 Methods of detecting micrometastasis of prostate cancer
08/23/1995EP0667918A1 Non-radioactive hybridization assay and kit
08/23/1995EP0667916A1 Crf binding protein
08/23/1995EP0667915A1 Protease-stable proteins
08/23/1995EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy
08/23/1995EP0667911A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
08/23/1995EP0667910A1 A bacillus promoter derived from a variant of a bacillus licheniformis x-amylase promoter
08/23/1995EP0667909A1 Biotechnological method of producing biotin
08/23/1995EP0667907A1 Nucleic acid coding for an alpha-acetolactate synthase from lactococcus and its applications
08/23/1995EP0667906A1 $g(b)-KETOACYL-ACP SYNTHETASE II GENES FROM PLANTS
08/23/1995EP0667905A1 Antifungal chitin binding proteins and dna coding therefor
08/23/1995EP0667904A1 Suppressor and progenitor cells
08/23/1995EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667900A1 Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene
08/23/1995EP0667899A1 Mutated growth factor receptor as medicament and its use for treating cancer
08/23/1995EP0667898A1 Tau/neurofilament protein kinases pk40 and pk36
08/23/1995EP0667872A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667869A1 Assay for inhibitors of farnesyl-protein transferase
08/23/1995EP0667858A1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667791A1 Isolation, growth, differentiation and genetic engineering of human muscle cells
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995EP0667778A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene
08/23/1995EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections
08/23/1995EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
08/23/1995EP0494929B1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/23/1995CN1107179A Method for the production of L-threonine by fermentation
08/23/1995CN1107160A Soluble covalence coupling carrier for molecular hybrid
08/22/1995US5444166 Constitutive triple response gene and mutations
08/22/1995US5444164 TGF-β induced gene
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444155 Molecules with antibody combining sites that induce asymmetry
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444151 Platelet derived growth factor antagonists
08/22/1995US5444044 Synthetic polypeptides as inhibitors of HIV-1
08/22/1995US5443980 Process to obtain extra-cellular recombinant products using Xanthomonas campestris pv campestris as host
08/22/1995US5443979 Synergistic mixture
08/22/1995US5443978 Cloned dna
08/22/1995US5443974 Transforming plants to control levels of saturated and unsaturated fatty acids
08/22/1995US5443969 In vivo system for expression and packaging a genetic engineered single stranded RNA of unlimited length into pseudovirus particles comprised of plant viral coat proteins; storage stability, ribonuclease resistant
08/22/1995US5443968 Fed batch culture method for protein secreting cells
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443966 Expression of tetanus toxin fragment C
08/22/1995US5443965 Peptide antigens used in diagnosis
08/22/1995US5443964 Poxvirus insertion/expression vector
08/22/1995US5443962 Methods of identifying inhibitors of cdc25 phosphatase
08/22/1995US5443957 Cancer diagnosis
08/22/1995US5443954 Immortalized non-tumorigenic human bronchial epithelial cell lines
08/22/1995US5443953 Genetic engineering; diagnosis, therapy
08/22/1995US5443831 A polynucleotide immunogens protecting chicken against viral disease
08/22/1995US5443828 AIDS vaccine
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis
08/22/1995US5443750 Homogenous endoglucanase which is immunoreactive with antibody raised against a highly purified cellulase; cleaner and fabric softener
08/17/1995WO1995022056A1 Highly specific surfaces for biological reactions, method of preparation and utilization
08/17/1995WO1995021939A1 Method for ordering macromolecules by means of a moving meniscus, and uses thereof
08/17/1995WO1995021938A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021929A1 Antifungal proteins, dna coding therefor, and hosts incorporating same
08/17/1995WO1995021928A1 Process for the production of a heterologous protein from a methylotrophic yeast
08/17/1995WO1995021927A2 Targeting gene therapy
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021925A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
08/17/1995WO1995021924A1 Expression of the glucose oxidase gene in transgenic organisms
08/17/1995WO1995021923A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor
08/17/1995WO1995021922A2 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/17/1995WO1995021921A1 Mammalian thymokine genes
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021919A2 Protein having tpo activity
08/17/1995WO1995021918A1 Rat osteosarcoma cell lines
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021916A2 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021914A1 Method for preparing a multicombinatorial library of antibody gene expression vectors
08/17/1995WO1995021913A1 Alteration of plant self-compatibility using genetic manipulation of the s-genes
08/17/1995WO1995021912A1 Non-pathogenic strains of hiv-1
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995WO1995021862A1 Isolated antigenic oncogene peptide fragments and uses
08/17/1995WO1995021861A1 Fk-506 cytosolic binding protein
08/17/1995WO1995021860A1 Methods for variation of chromatin condensation
08/17/1995WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995WO1995021853A1 High-affinity ligands of basic fibroblast growth factor and thrombin
08/17/1995WO1995021849A1 Process for separating double-stranded/single-stranded nucleic acid structures
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
1 ... 3748 3749 3750 3751 3752 3753 3754 3755 3756 3757 3758 3759 3760 3761 3762 3763 3764 3765 3766 3767 3768 ... 4023